Lagarde Michel 4

What Happened

• Michel Lagarde, Executive Vice President of Thermo Fisher Scientific (TMO), reported two share dispositions on Feb 28, 2026 to satisfy tax obligations tied to equity compensation.
• He surrendered 836.880 shares at $521.11 each ($436,107) and 359.725 shares at $521.11 each ($187,456), for a combined 1,196.605 shares surrendered and a total value of approximately $623,563.
• This was a tax-withholding/settlement of equity (routine disposition), not an open-market sale or a new purchase.

Key Details

• Transaction date: 2026-02-28; Report filed: 2026-03-02 (filed within the typical Form 4 window).
• Prices: $521.11 per share for both entries.
• Shares surrendered: 836.880 and 359.725 (total 1,196.605).
• Total value surrendered: ~$436,107 and ~$187,456 (total ~$623,563).
• Transaction code: F — payment of exercise price or tax liability via share surrender (withholding).
• Shares owned after transaction: not specified in the provided filing excerpt.
• No indication this was part of a 10b5-1 plan or an open-market sale in the reported lines.

Context

• This is a routine tax-withholding event commonly seen when executives exercise options or when restricted stock vests. Shares are surrendered to cover taxes rather than sold on the open market, so this does not necessarily signal a change in the insider’s view of the company.
• For retail investors, genuine buying activity (direct purchases) is generally a stronger indicator of insider confidence than tax-related withholdings or other automatic dispositions.